Navigation Links
Orexigen Therapeutics to Present at the Jefferies 2013 Global Healthcare Conference
Date:5/30/2013

SAN DIEGO, May 30, 2013 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at the Jefferies 2013 Global Healthcare Conference in New York. The presentation is scheduled for Monday, June 3rd at 12:30 p.m. Eastern Time. To listen to the live webcast or a replay of the presentation, please visit the Investor Relations section of the Company's Web site at www.orexigen.com. A replay will be available for 14 days after the event.

About Orexigen® Therapeutics
Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead product candidate is Contrave®, which has completed Phase 3 clinical trials and for which a New Drug Application has been submitted and reviewed by the FDA. The Company has also reached agreement with the FDA on a Special Protocol Assessment (SPA) for the Light Study, the Contrave cardiovascular outcomes trial. The Company's other product candidate, Empatic™, has completed Phase 2 clinical trials. Further information about the Company can be found at www.orexigen.com.Orexigen Contact:

Media Contact:  McDavid Stilwell

Denise PowellVP, Corporate Communications and Business Development

BrewLife(858) 875-8629

(510) 703-9491


'/>"/>
SOURCE Orexigen Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Orexigen Therapeutics to Present at the UBS Global Healthcare Conference
2. Orexigen Therapeutics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012
3. Orexigen Therapeutics to Host Full Year and Fourth Quarter 2012 Financial Results Conference Call and Webcast
4. Orexigen Therapeutics Announces Webcast of Upcoming Presentation at the Cowen & Co. Annual Health Care Conference
5. Orexigen Therapeutics to Present at Upcoming Investor Conferences
6. Orexigen Therapeutics To Host Analyst Day Event on December 18, 2012
7. Orexigen Therapeutics Reports Financial Results for the Third Quarter Ended September 30, 2012
8. Orexigen Therapeutics announces continued rapid enrollment into the Light Study; enrollment now expected to close by year end 2012
9. Orexigen Therapeutics Announces Presentations at Upcoming Investor Conferences
10. Orexigen Therapeutics Reports Financial Results for the Second Quarter Ended June 30, 2012
11. Orexigen Therapeutics Schedules August 7, 2012 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... Ill. , May 5, 2015 ... diagnostic testing equipment and information systems technology, today ... information systems company. This partnership allows Sysmex and ... and interfacing solution for physician offices and clinics ... directly to Electronic Medical Record (EMR) systems. ...
(Date:5/5/2015)... -- GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, ... on discovering, developing and commercializing novel therapeutics from ... closing of the previously announced offering on the ... Depositary Shares (ADSs) at a price of $112.00 ... million (before deducting underwriting discount, commissions and offering ...
(Date:5/5/2015)... YORK , May 5, 2015  IBM Watson ... is collaborating with more than a dozen leading cancer ... and personalize treatment options for their patients. The institutes ... capabilities to reduce from weeks to minutes the ability ... and gather relevant information from medical literature to personalize ...
Breaking Medicine Technology:Sysmex America, Inc. Partners with Medicus Middleware to Provide Physician Office Labs with Instrument Connectivity Directly to EMR 2Sysmex America, Inc. Partners with Medicus Middleware to Provide Physician Office Labs with Instrument Connectivity Directly to EMR 3GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 2GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 3GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 4Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 2Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 3Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 4Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 5Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 6
(Date:5/6/2015)... 2015 Healthcare marketing agency Smith ... silver award in the 2015 Aster Awards for its ... Ellis Medicine’s maternity campaign, respectively. The Aster Awards recognize ... and marketing agencies. , The branding campaign for ... — other/misc. category and hospital 150-200 bed group. The ...
(Date:5/6/2015)... 06, 2015 The SGNY Group LLC ... City, announced today that it was named a Platinum ... presentation video produced on behalf of Intarcia Therapeutics. ... of motion graphics. , The competition sponsored by the ... 6000 entries from 22 countries. The competition is ...
(Date:5/6/2015)... May 06, 2015 The beverage industry ... drinks. Little Miracles organic tea and superfruit fusions stands ... ginseng and sweetened with agave, these delicious juice blends ... that seeks healthier ways to hydrate. , In collaboration ... invites people to raise a bottle of Lemongrass Tea ...
(Date:5/5/2015)... 05, 2015 With the FCPX LUT: Monochromatic ... and easily add washed color grades to footage. A LUT ... modifying an image. The LUT changes every pixel's color to ... with 90 washed CUBE LUT files. , This plugin was ... give any footage a washed look. , CUBE LUT ...
(Date:5/5/2015)... Hills Cosmetic Dentist, Arthur Glosman released a luxury line of ... the offices of Arthur Glosman DDS, 450 N Roxbury Drive ... online store . “I wanted to be one of the ... beauty with a luxurious collection of products designed to make ... Dr. Glosman’s Advanced Dental Health + Beauty™ products use a ...
Breaking Medicine News(10 mins):Health News:Smith & Jones Wins in 2015 Aster Awards for Healthcare Marketing 2Health News:The SGNY Group Wins Platinum Hermes Creative Award 2Health News:Say Cheers to National Beverage Day with Little Miracles 2Health News:Pixel Film Studios Announced the Release of FCPX LUT Monochromatic 2Health News:Beverly Hills Dentist Arthur Glosman Launches New Dental Health And Beauty Product Line 2
... which is a serious problem in people with cancer, AIDS ... lungs and heart. A recent study has found that the ... flies, where it is involved in muscle development, could help ... have been studying the function of the twist gene in ...
... in Chapel Hill that was published in the Jan. 15 ... - C282Y and H63D, which are linked to the iron ... of developing colon cancer. For the research, the genes of ... than 400 already had colon cancer, and were matched with ...
... Researchers from the department of urology in a ... response to hormone-refractory prostate cancer could be measured ... prostate cancer doubling time may be an auxiliary ... hormone refractory prostate cancer. ,The study was ...
... psychologists at the Tufts University in Boston has revealed that ... emotions displayed on television. They also use emotional information picked ... Mumme, assistant professor of psychology at Tufts University, and her ... objects such as a red spiral letter holder, a blue ...
... outlines a new method developed by Microbia Ltd.'s ... production of industrial molecules produced in microbes. This ... improve the properties// of microbial cells for biomanufacturing ... the illumination of the best route to optimize ...
... by researchers at Pace University in New York found from ... 1993 until 1999 found that the percentage of women who ... more than half of those were unable to remain ex-smokers ... the American Journal of Preventive Medicine suggested that the results ...
Cached Medicine News:
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: